Norris Medicines Ltd Holds 35th AGM, Discusses Financials
Norris Medicines Limited conducted its 35th Annual General Meeting (AGM) on September 29, 2026, via video conferencing. The meeting, which commenced at 2:30 PM IST and concluded at 2:45 PM IST, addressed several key agenda items. These included the adoption of audited financial statements for the year ended March 31, 2026, the re-appointment of a director retiring by rotation, and special business concerning the appointment of Mr. Vimal D. Shah as Managing Director. Additionally, resolutions were proposed to increase borrowing limits, authorize the disposal of the company's undertaking, and enhance limits under Section 186 of the Companies Act, 2013. The results of the e-voting will be announced within two working days.
Key Highlights
- 35th AGM held via video conference on September 29, 2026.
- Key agenda items included financial statements and director appointments.
- Special resolutions proposed for borrowing limits and asset disposal.
- Mr. Vimal D. Shah appointed as Managing Director.
- E-voting results to be announced within two business days.
Price Impact
More from NORRIS